Literature DB >> 30775995

White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.

Anna Damulina1, Lukas Pirpamer1, Stephan Seiler2, Thomas Benke3, Peter Dal-Bianco4, Gerhard Ransmayr5, Walter Struhal5,6, Edith Hofer1, Christian Langkammer1, Marco Duering7, Franz Fazekas1, Reinhold Schmidt1.   

Abstract

BACKGROUND/
OBJECTIVE: Higher white matter hyperintensity (WMH) load has been reported in Alzheimer's disease (AD) patients in different brain regions when compared to controls. We aimed to assess possible differences of WMH spatial distribution between AD patients and age-matched controls by means of lesion probability maps.
METHODS: The present study included MRI scans of 130 probable AD patients with a mean age of 73.4±8.2 years from the Prospective Dementia Registry Austria Study and 130 age-matched healthy controls (HC) from the Austrian Stroke Prevention Family Study. Risk factors such as hypertension, diabetes mellitus, hypercholesterolemia, coronary artery disease, and smoking were assessed. Manually segmented FLAIR WMH masks were non-linearly registered to a template and voxel-based probability mapping was performed.
RESULTS: There were no significant between-group differences in cardiovascular risk factors and WMH volume. AD patients showed a significantly higher likelihood of having WMH in a bilateral periventricular distribution than controls before and after correcting for age, sex, cardiovascular risk factors, and ventricular volume (p≤0.05; threshold-free cluster enhancement corrected). There was no significant association between the periventricular WMH volume and cognitive decline of AD patients.
CONCLUSION: In AD, WMH were preferentially found in a periventricular location but the volume of lesions was unrelated to cognitive decline in our study irrespective of lesion location.

Entities:  

Keywords:  Alzheimer’s disease; magnetic resonance imaging; periventricular white matter; white matter hyperintensities

Mesh:

Year:  2019        PMID: 30775995     DOI: 10.3233/JAD-180982

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  ADataViewer: exploring semantically harmonized Alzheimer's disease cohort datasets.

Authors:  Yasamin Salimi; Daniel Domingo-Fernández; Carlos Bobis-Álvarez; Martin Hofmann-Apitius; Colin Birkenbihl
Journal:  Alzheimers Res Ther       Date:  2022-05-21       Impact factor: 8.823

2.  Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.

Authors:  Min-Chien Tu; Hsiao-Wen Chung; Yen-Hsuan Hsu; Jir-Jei Yang; Wen-Chau Wu
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer's disease.

Authors:  Neil P Oxtoby; Colin Birkenbihl; Sepehr Golriz Khatami; Yasamin Salimi; Martin Hofmann-Apitius
Journal:  Alzheimers Res Ther       Date:  2022-04-20       Impact factor: 8.823

Review 4.  Common Brain Structural Alterations Associated with Cardiovascular Disease Risk Factors and Alzheimer's Dementia: Future Directions and Implications.

Authors:  Melissa Lamar; Elizabeth A Boots; Konstantinos Arfanakis; Lisa L Barnes; Julie A Schneider
Journal:  Neuropsychol Rev       Date:  2020-10-03       Impact factor: 7.444

5.  White matter hyperintensity topography in Alzheimer's disease and links to cognition.

Authors:  Antoine Garnier-Crussard; Salma Bougacha; Miranka Wirth; Sophie Dautricourt; Siya Sherif; Brigitte Landeau; Julie Gonneaud; Robin De Flores; Vincent de la Sayette; Denis Vivien; Pierre Krolak-Salmon; Gaël Chételat
Journal:  Alzheimers Dement       Date:  2021-07-28       Impact factor: 16.655

6.  Prediction of cognitive performance in old age from spatial probability maps of white matter lesions.

Authors:  Cui Zhao; Ying Liang; Ting Chen; Yihua Zhong; Xianglong Li; Jing Wei; Chunlin Li; Xu Zhang
Journal:  Aging (Albany NY)       Date:  2020-03-19       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.